Related Experiment Video
Updated: Jan 3, 2026
09:57
In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
10.6K
Dexamethasone: chondroprotective corticosteroid or catabolic killer?
1MIT, Centre for Biomedical Engineering, 500 Technology Square, Cambridge, MA, 02139, USA.alg@mit.edu.
European Cells & Materials
|November 23, 2019
Summary
Dexamethasone (DEX) shows promise for treating osteoarthritis by protecting cartilage. However, its safety and effectiveness depend on dosage and exposure, requiring further study for clinical use as a disease-modifying osteoarthritis drug.
Area of Science:
- Biomedical Sciences
- Rheumatology
- Pharmacology
Background:
- Glucocorticoids are widely used for osteoarthritis and rheumatoid arthritis pain.
- Their use is controversial due to potential harmful side effects.
- Dexamethasone (DEX) has shown potential in preclinical models for osteoarthritis.
Purpose of the Study:
- To evaluate the conflicting literature on dexamethasone's effects on cartilage.
- To understand conditions under which DEX may be beneficial or harmful to cartilage.
- To determine the potential for safe clinical use of DEX as a disease-modifying drug.
Main Methods:
- Review of animal studies and cartilage explant models.
- Analysis of research on DEX effects on cartilage matrix, chondrocyte viability, and apoptosis.
- Examination of dose and duration-dependent effects of DEX exposure.
Main Results:
- DEX demonstrated cartilage protection in models of osteoarthritis and tissue injury.
- Conflicting results exist regarding DEX safety, with some studies showing increased chondrocyte apoptosis in healthy cartilage models.
- DEX has shown benefits in reducing matrix loss and inflammation in arthritis models.
Conclusions:
- DEX may offer disease-modifying potential for osteoarthritis.
- Understanding specific conditions for DEX use is crucial to mitigate risks.
- Further research is needed to establish safe and effective clinical protocols for DEX in osteoarthritis treatment.
More Related Videos
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.4K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.4K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
377
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
377
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
428
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
428
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:21Skeletal Muscle Relaxants: Adverse Effects
741
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
741
01:26COPD: Management Using Bronchodilators and Corticosteroids
679
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
679